Cohort of Patients With Chronic Myelomonocytic Leukemia
Recruiting
Observational Study
Leukemia
Myelomonocytic Leukemia, Chronic
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 5,000 (estimated)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A prospective, non-interventional study involving the collection of biological samples with associated anonymised data. Biological samples will be collected at the time of diagnosis and/or as the disease progresses, with or without treatment, always in conjunction with tests scheduled as part of routine care or within the context of a clinical trial.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18 years and over
* Blood monocytosis ≥ 0.5 × 10⁹/L and ≥ 10% of total white blood cells or
* Confirmed diagnosis of chronic myelomonocytic leukemia
* Regardless of stage (chronic or transformed), and whether or not currently being treated
* Signed informed consent…
Contacts